Literature DB >> 10658193

Acute ultrastructural effects of MPTP on the nigrostriatal pathway of the C57BL/6 adult mouse: evidence of compensatory plasticity in nigrostriatal neurons.

J A Cochiolo1, R Ehsanian, D K Bruck.   

Abstract

Acute doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) elicited degenerative and apparently compensatory changes in the nigrostriatum of injected animals within 1 day of treatment. In the substantia nigra pars compacta (SNc), low-dose (20 mg/kg) administration elicited early degeneration of mitochondria in the absence of other effects. In the striatum, a low MPTP dose resulted in myelin unwinding, demyelination, cytoplasmic shrinkage, and disturbance of synaptic communication, as evinced by a profound reduction in synaptic vesicle production. High-dose (40 mg/kg) administration generated more drastic axonal degeneration leading to cell elimination in the striatum. At neither dose was mitochondrial disturbance evident in the striatum. Evidence is presented that darkened synaptic boutons, visible at this level of MPTP administration, were part of healthy enlarged axons with an elevated number of synaptic contacts. These spared neuronal processes, therefore, were hypothesized to compensate for the MPTP-induced death of dopaminergic neurons by adaptive structural modifications that would serve to enhance their functional capability.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10658193

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  9 in total

1.  Early and late gene changes in MPTP mice model of Parkinson's disease employing cDNA microarray.

Authors:  Silvia Mandel; Edna Grünblatt; Gila Maor; Moussa B H Youdim
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

2.  Temporal mRNA profiles of inflammatory mediators in the murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine model of Parkinson's disease.

Authors:  R Pattarini; R J Smeyne; J I Morgan
Journal:  Neuroscience       Date:  2007-01-29       Impact factor: 3.590

3.  DLP1-dependent mitochondrial fragmentation mediates 1-methyl-4-phenylpyridinium toxicity in neurons: implications for Parkinson's disease.

Authors:  Xinglong Wang; Bo Su; Wanhong Liu; Xiaohua He; Yuan Gao; Rudy J Castellani; George Perry; Mark A Smith; Xiongwei Zhu
Journal:  Aging Cell       Date:  2011-06-14       Impact factor: 9.304

4.  1-Methyl-4-phenylpyridinium affects fast axonal transport by activation of caspase and protein kinase C.

Authors:  G Morfini; G Pigino; K Opalach; Y Serulle; J E Moreira; M Sugimori; R R Llinás; S T Brady
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-07       Impact factor: 11.205

5.  GSTpi expression in MPTP-induced dopaminergic neurodegeneration of C57BL/6 mouse midbrain and striatum.

Authors:  Margarida Castro-Caldas; Andreia Neves Carvalho; Isabel Peixeiro; Elsa Rodrigues; Maria Celeste Lechner; Maria João Gama
Journal:  J Mol Neurosci       Date:  2008-09-16       Impact factor: 3.444

6.  Methamphetamine causes degeneration of dopamine cell bodies and terminals of the nigrostriatal pathway evidenced by silver staining.

Authors:  Sara Ares-Santos; Noelia Granado; Isabel Espadas; Ricardo Martinez-Murillo; Rosario Moratalla
Journal:  Neuropsychopharmacology       Date:  2013-10-30       Impact factor: 7.853

7.  Microtubule alterations occur early in experimental parkinsonism and the microtubule stabilizer epothilone D is neuroprotective.

Authors:  Daniele Cartelli; Francesca Casagrande; Carla Letizia Busceti; Domenico Bucci; Gemma Molinaro; Anna Traficante; Daniele Passarella; Erminio Giavini; Gianni Pezzoli; Giuseppe Battaglia; Graziella Cappelletti
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

8.  Adenosine A(2A) receptors in Parkinson's disease treatment.

Authors:  Marek Cieślak; Michał Komoszyński; Andrzej Wojtczak
Journal:  Purinergic Signal       Date:  2008-04-26       Impact factor: 3.765

Review 9.  Glial-mediated inflammation underlying parkinsonism.

Authors:  Carlos Barcia
Journal:  Scientifica (Cairo)       Date:  2013-07-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.